HAEMONETICS CORP (HAE) is a publicly traded company in the Unknown sector. Across all available filings, 45 corporate insiders have executed 1011 transactions totaling $109.7M, demonstrating a bearish sentiment with -$104.7M in net insider flow. The most recent transaction on Nov 10, 2025 involved a purchase of 1,400 shares valued at $98.8K.
No significant insider buying has been recorded for HAE in the recent period.
No significant insider selling has been recorded for HAE in the recent period.
Based on recent SEC filings, insider sentiment for HAE is bearish with an Insider Alignment Score of 2/100 and a net flow of -$104.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at HAEMONETICS CORP (HAE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 45 insiders are actively trading HAE stock, having executed 1011 transactions in the past 90 days. The most active insider is Christopher Simon, (Executive), who has made 51 transactions totaling $59.8M.
Get notified when executives and directors at HAE file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | W. Kroll Mark | Executive | Purchase | 1,400 | $70.56 | $98.8K | |
| Oct 31, 2025 | Galvin Roy | Executive | Payment | 145 | $50.01 | $7.3K | |
| Sep 17, 2025 | A. Miller Laurie | Executive | Payment | 238 | $49.95 | $11.9K | |
| Jul 24, 2025 | E. Abernathy Robert | Executive | Award | 2,693 | $N/A | $0 | |
| Jul 24, 2025 | M. Bryant Diane | Executive | Award | 2,693 | $N/A | $0 | |
| Jul 24, 2025 | J. Coyle Michael | Executive | Award | 2,693 | $N/A | $0 | |
| Jul 24, 2025 | J. Dockendorff Charles | Executive | Award | 2,693 | $N/A | $0 | |
| Jul 24, 2025 | Emerson Johnson Lloyd | Executive | Award | 2,693 | $N/A | $0 | |
| Jul 24, 2025 | W. Kroll Mark | Executive | Award | 2,693 | $N/A | $0 | |
| Jul 24, 2025 | Pomeroy Claire | Executive | Award | 2,693 | $N/A | $0 | |
| Jul 24, 2025 | M. Zane Ellen | Executive | Award | 2,693 | $N/A | $0 | |
| Sep 17, 2024 | A. Miller Laurie | Executive | Payment | 238 | $76.54 | $18.2K | |
| Aug 29, 2024 | Simon, Christopher | Executive | Other | 39,704 | $75.56 | $3.0M | Large |
| Jul 26, 2024 | W. Strong Stewart | Executive | Sale | 4,312 | $91.15 | $393.0K | 10b5-1 |
| Jul 25, 2024 | M. Zane Ellen | Executive | Award | 2,207 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 484 | $107.2M | 57.2% |
Exercise(M) | 162 | $41.3M | 22.0% |
Payment(F) | 65 | $27.1M | 14.5% |
Award(A) | 235 | $5.1M | 2.7% |
Other(J) | 1 | $3.0M | 1.6% |
Purchase(P) | 3 | $2.5M | 1.3% |
Disposition(D) | 51 | $1.4M | 0.7% |
Gift(G) | 10 | $0 | 0.0% |
Insider selling pressure at HAEMONETICS CORP has increased, with 45 insiders executing 1011 transactions across all time. Total sales of $107.2M significantly outpace purchases of $2.5M, resulting in a net outflow of $104.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.